Not to say you're wrong - I like your post, but personally my confidence between 1 and 2 is inverted.
Biotech might stay down, clinical programs delayed, RAC's cards might have to stay close to the chest to protect IP. It's probable that the SP will recover quickly from here - but the market has been irrational so far, nothing to say it won't stay this way for a lot longer.
But you can bet the house (and I know several who have) that the true, breathtaking value of Cardioprotection and BIC/FIC inhibition of FTO will be acknowledged by BP and the market in the end.
"In the short run, the market is a voting machine, but in the long run, it is a weighing machine" - Warren Buffet
RAC Price at posting:
$1.22 Sentiment: Buy Disclosure: Held
